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Background: Human gut microbiota plays an important role in the pathogenesis of cirrhosis complications.
Although the phylogenetic diversity of intestinal microbiota in patients with liver cirrhosis has been examined in
several studies, little is known about their functional composition and structure.
Results: To characterize the functional gene diversity of the gut microbiome in cirrhotic patients, we recruited a
total of 42 individuals, 12 alcoholic cirrhosis patients, 18 hepatitis B virus (HBV)-related cirrhosis patients, and 12
normal controls. We determined the functional structure of these samples using a specific functional gene array,
which is a combination of GeoChip for monitoring biogeochemical processes and HuMiChip specifically designed
for analyzing human microbiomes. Our experimental data showed that the microbial community functional
composition and structure were dramatically distinctive in the alcoholic cirrhosis. Various microbial functional genes
involved in organic remediation, stress response, antibiotic resistance, metal resistance, and virulence were highly
enriched in the alcoholic cirrhosis group compared to the control group and HBV-related cirrhosis group. Cirrhosis
may have distinct influences on metabolic potential of fecal microbial communities. The abundance of functional
genes relevant to nutrient metabolism, including amino acid metabolism, lipid metabolism, nucleotide metabolism,
and isoprenoid biosynthesis, were significantly decreased in both alcoholic cirrhosis group and HBV-related cirrhosis
group. Significant correlations were observed between functional gene abundances and Child-Pugh scores, such as
those encoding aspartate-ammonia ligase, transaldolase, adenylosuccinate synthetase and IMP dehydrogenase.
Conclusions: Functional gene array was utilized to study the gut microbiome in alcoholic and HBV-related cirrhosis
patients and controls in this study. Our array data indicated that the functional composition of fecal microbiomes
was heavily influenced by cirrhosis, especially by alcoholic cirrhosis. This study provides new insights into the
functional potentials and activity of gut microbiota in cirrhotic patients with different etiologies.
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The gastrointestinal tract harbors a complex and diverse
microbial community, which plays important roles in host
nutrition, immune function, health and disease. Increasing
evidence suggests that dysbiosis of intestinal microbiota
plays important roles in the pathogenesis of complications
of cirrhosis, such as spontaneous bacterial peritonitis, and* Correspondence: ljli@zju.edu.cn; jzhou@ou.edu
1State Key Laboratory for Diagnosis and Treatment of Infectious Disease,
Collaborative Innovation Center for Diagnosis and Treatment of Infectious
Diseases, The First Affiliated Hospital, Zhejiang University, Hangzhou 310003,
PR China
2Institute for Environmental Genomics, Department of Microbiology and
Plant Biology, University of Oklahoma, Norman, OK 73019, USA
Full list of author information is available at the end of the article
© 2014 Chen et al.; licensee BioMed Central L
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.hepatic encephalopathy [1]. Bacterial translocation has
been postulated as the main mechanism [2]. And intes-
tinal bacterial overgrowth is one of the most important
factors that facilitate bacterial translocation in cirrhosis
[3]. Most recently, culture-independent methods including
real-time PCR and high-throughput sequencing were used
to characterize the structure of fecal microbiota in cir-
rhotic patients. Compositional changes have been linked
with cirrhosis, including a significant increase of Proteo-
bacteria and Fusobacteria, and a corresponding decrease
of Bacteroidetes in cirrhotic patients using 454 sequencing
of 16S rDNA gene [4]. Abnormal fecal microbiota func-
tions in patients with hepatitis B virus (HBV) livertd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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nomic sequencing [5].
Metagenomic pyrosequencing of intestinal microbiota
have led to the discovery of novel genes from uncultivated
microorganisms, assembly of whole genomes from com-
munity DNA sequence data and comparison of microbial
community composition under different physical condi-
tions [6]. The human gut microbiome has significantly
enriched metabolism of carbohydrates, amino acids, and
xenobiotics, and biosynthesis of vitamins and isoprenoids,
when compared with the average content of previous se-
quenced microbial genome [7]. There are a wide array of
shared microbial genes among sampled individuals, com-
prising an extensive, identifiable ‘core microbiome’ at the
gene level [8]. Several studies have described changes in
the gene content of the gut microbiome across health and
disease [9-11].
Functional gene arrays (FGAs) are the microarrays con-
taining probes which target genes involved in a variety of
functional processes and are powerful high throughput
tools for monitoring the physiological status and func-
tional activities of microbial populations and communities
[12-14]. Different types of FGAs have been developed for
analyzing microbial functional community structure [15],
such as, GeoChip 4.0, which contains about 82,000 probes
and targets about 142,000 genes from 410 functional gene
families involved in nitrogen, carbon, sulfur and phos-
phorus cycling, antibiotic resistance, virulence factors and
bacterial phage-mediated lysis (Additional file 1: Table S1),
and HuMiChip 1.0, which contains 36,082 probes target-
ing ~50,000 gene coding DNA sequences from 139 key
functional genes in various metabolic pathways (e.g., the
metabolism of amino acids, carbohydrates, energy, lipids,
glycan, cofactors, vitamins, and nucleotides) (Additional
file 2: Table S2). Since human microbiomes have many
general functions which GeoChip targets, combining these
two types of FGAs would be very powerful in dissecting
the functional composition and structure of human
microbiomes.
We hypothesized that gut dysbiosis in cirrhosis would
be related to altered microbial functional structure and
that the etiology of cirrhosis would further affect the gut
microbiome. Alcoholic and HBV are the main causes of
cirrhosis in Western country and China, respectively. In
this study, we characterized the functional structure of
fecal microbial communities in patients with alcoholic
cirrhosis and HBV-related cirrhosis compared to healthy
controls using GeoChip 4.0 + HuMiChip 1.0. We fo-
cused on the variations of fecal microbiomes in relation
to (i) the presence of cirrhosis and (ii) the etiology of cir-
rhosis, for example, chronic alcohol consumption. Our
results indicated that cirrhosis, especially alcoholic cir-
rhosis, has a tremendous impact in the functional com-
position of fecal microbiomes.Results
Overview of functional gene diversity and structure of
fecal microbial communities
Based on all detected functional genes, the community
diversity was assessed by richness (number of probes de-
tected per sample), Shannon-Weiner (H’) and Simpson’s
(1/D) indices (Figure 1). Overall, the number of probes
detected was significantly (p < 0.01) higher in alcoholic
cirrhosis (ALC) than in HBV-related cirrhosis (HBC)
and controls (CT), while there was no significant differ-
ence between the HBC and CT groups. Similarly, the
overall microbial functional diversity was also signifi-
cantly (p < 0.001) higher in ALC than in HBC and CT
based on Shannon-Weiner (H’) and Simpson’s (1/D) in-
dices, while the difference was not significant between
HBC and CT groups.
Detrended correspondence analysis (DCA) of all de-
tected genes was used to examine overall functional
structure changes in the microbial communities. Result-
ing ordination plots showed a marked difference among
the three groups and explained 46.3% of the total varia-
tions (Figure 2). ALC samples were clearly separated
from HBC and CT samples along DCA1 (31.2%), while
HBC and CT were distinct along DCA2 (15.1%).
The average signal intensities of functional categories
were compared among the three groups (Figure 3). The
functional categories involved in nutrient metabolism
were significantly (p < 0.05) lower in ALC and HBC than
in CT, including the functional categories of isoprenoid
biosynthesis, lipid metabolism, nucleotide metabolism,
and amino acid biosynthesis and metabolism. For glycan
biosynthesis and metabolism and cofactor biosynthesis,
the relative abundance was significantly (p < 0.05) lower
in ALC than in CT, while the difference was not signifi-
cant between HBC and CT group. Functional categories,
such as energy metabolism, organic remediation, stress
response, antibiotic resistance, metal resistance and viru-
lence, were significantly (p ≤ 0.001) enriched in ALC
compared to CT and HBC, while there was no signifi-
cant difference between HBC and CT.
Shifts of genes in response to cirrhosis
Cirrhosis mostly affected the abundance of functional
genes involved in nutrient metabolism. In this study, we
identified 33 genes, whose alteration was consistent be-
tween HBC and ALC relative to controls (Figure 4).
(i) Amino acid biosynthesis and metabolism. A total of
11 genes involved in amino acid biosynthesis and
metabolism were detected significantly (p < 0.05)
reduced in both cirrhosis group, including amino acid
biosynthesis genes (2-isopropylmalate synthase gene,
cysteine synthase A gene, NADPH gene, L-threonine
aldolase gene, prephenate dehydrogenase gene, serine
Figure 1 (See legend on next page.)
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Figure 1 Number of probes detected and diversities of the microbial community in alcoholic cirrhosis, HBV-related cirrhosis, and
controls. Gene number (Figure 1A), Simpson Index (Figure 1B), and Shannon Index (Figure 1C) were presented as mean ± SD. Different letters
above the bar (a, b) indicated statistical difference at a P value of <0.05 among groups by one-way ANOVA and Tukey’s test. HBV-related cirrhosis
(HBC), healthy controls (CT), and alcoholic cirrhosis (ALC).
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ferase gene, serine-tRNA ligase gene, and aspartate-
ammonia ligase gene), and amino acid metabolism
genes (glutamate decarboxylase A and B PLP-
dependent gene, and lysine decarboxylase 1 gene).
(ii) Carbohydrate metabolism. Carbohydrate
metabolism is one of the most important functions the
distal gut microbiome provides for the host. The
abundance of genes involved in carbohydrate
metabolism was significantly (p < 0.05) lower in ALC
and HBC than in CT, including genes for KDPG
aldolase, transaldolase, glycogen synthase, ribokinase,
N-acetylglucosamine-6-phosphate deacetylase, and
beta-D-galactosidase. Butyrate serves as the principal
energy source for colonocytes and may fortify the intes-
tinal mucosal barrier by stimulating their growth [16].
The genes encoding butyrate kinase, which participate
in butyrate metabolism, were significantly (p < 0.001)
lower in HBC than in CT, and even lower in ALC than
in HBC.
(iii) Glycan biosynthesis and metabolism. The array
data demonstrated 5 genes of glycan biosynthesis and
metabolism significantly declined in both cirrhosis
groups relative to controls, including D-alanineD-
alanine ligase gene, UDP-N-acetylglucosamineFigure 2 Detrended correspondence analysis of the array data. Circles in
healthy controls (CT), and triangles indicate samples with alcoholic cirrhosis (Aacyltransferase gene, UDP-N-acetylmuramateL-alanine
ligase gene, phospho-N-acetylmuramoyl-pentapeptide
transferase gene, and UDP-N-acetylmuramoyl-L-alanyl-
D-glutamatemeso-diaminopimelate ligase gene
(p < 0.05).
(iv) Nucleotide metabolism. The abundance of genes
involved in nucleotide metabolism was significantly
(p < 0.05) lower in ALC and HBC than in CT, including
genes for purine metabolism (adenylosuccinate
synthetase gene, IMP dehydrogenase gene, and purine-
nucleoside phosphorylase gene), and pyrimidine metab-
olism (carbamoyl phosphate synthetase small subunit
glutamine amidotransferase gene, thioredoxin reductase
FAD-NADP-binding gene, and thymidine phosphoryl-
ase gene).
(v) Cofactor biosynthesis and others. For cobalt
chelatase gene (encoding vitamin B12) and
pantothenate synthetase gene (encoding pantothenic
acid), the signal intensities were significantly (p < 0.001)
lower in ALC and HBC than in CT. The signal
intensities of isoprenoid biosynthesis gene encoding 4-
diphosphocytidyl-2C-methyl-D-erythritol synthase were
significantly (p < 0.05) lower in ALC and HBC than in
CT. Bacterial bile salt hydrolase participates in the con-
version of primary bile acids to secondary bile acidsdicate samples with HBV-related cirrhosis (HBC), squares indicate
LC).
Figure 3 The signal intensities of detected functional categories in alcoholic cirrhosis, HBV-related cirrhosis, and controls. All data are
presented as mean ± s.e. Different letters above the bar (a, b) indicate statistical difference at a P value of <0.05 among groups by one-way
ANOVA and Tukey’s test. No letter was labelled if there was no significant difference observed.
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lase gene was found significantly (p < 0.05) lower in
HBC than in CT, and even lower in ALC than in HBC
samples.
Correlations between gene abundance and child-pugh
scores
Among those genes with decreased abundances in both cir-
rhosis groups, we found 7 genes negatively correlated with
the severity of liver disease, as estimated by the Child-Pugh
score, including aspartate-ammonia ligase gene (r = −0.427,
p = 0.019), serine-tRNA ligase gene (r = −0.406, p = 0.026),
and glutamate decarboxylase A and B PLP-dependent gene
(r = −0.453, p = 0.012) for amino acid metabolism, transal-
dolase gene (r = −0.397, p = 0.03) for carbohydrate metabol-
ism, phospho-N-acetylmuramoyl-pentapeptide transferase
gene (r = −0.463, p = 0.014) for glycan metabolism, adenylo-
succinate synthetase gene (r = −0.449, p = 0.013) and IMP
dehydrogenase gene (r = −0.409, p = 0.025) for purine me-
tabolism (Figure 5).
Shifts of genes in response to alcohol
A comparison of ALC with HBC and CT revealed that
92 genes were uniquely altered in response to alcohol
consumption (Figure 6). Among them, 4 genes were
found significantly (p < 0.05) reduced in ALC than
in HBC and CT, including carbohydrate metabolism
gene (phosphogluconate dehydratase gene) and glycan
biosynthesis and metabolism gene (beta-N-acetyl-D-hexosaminide N-acetylhexosaminohydrolase gene, N-
acetyl-D-galactosamine-4-sulfate 4-sulfohydrolase gene,
and N-acetylmuramoyl-L-alanine amidase gene). Most
of the over-represented genes were involved in func-
tional categories of organic remediation, stress response,
and antibiotic or metal resistance. The abundance of
cytochrome gene in energy metabolism was found sig-
nificantly increased in ALC than in HBC and CT.
(i) Organic degradation. A substantial number of genes
(42) involved in degradation of organic compounds were
detected with different abundances, especially those
involved in degrading aromatic carboxylic acid, BTEX
and related aromatics, chlorinated aromatics, herbicides
and pesticides related compounds, and chlorinated
solvents. Most of these genes (e.g., pimF, nagG, nmoA,
and bphA, Catechol genes, GCoADH genes) showed
significantly (p < 0.05) increased abundances in ALC than
in CT and HBC (Additional file 1: Table S1). Phthalates
within alcoholic beverages have attracted more and more
attention for their health hazards in recent years. The
abundance of phtA gene, encoding phthalate 4, 5-
dioxygenase, was significantly (p < 0.001) higher in ALC
than in HBC and CT.
(ii) Stress response. A total of 24 genes involved in
stress response showed significantly (p < 0.05)
increased abundances in ALC than in CT and HBC,
including oxygen stress (ahpC, ahpF, fnr, katE, and
oxyR), oxygen limitation (narH, and narJ), nitrogen
Figure 4 Abundance distributions of the 33 functional genes in response to cirrhosis. This is a heat map showing abundance distributions
of the 33 functional genes in response to cirrhosis. The colume is sample, with the sample name and cluster matrix on the top of the figure. The
row is the gene signal intensity, with the gene name on the right. The color intensity indicates difference in signal intensities. To show the
distribution of the genes with lower abundance, the colored squares of each row were scaled to indicate the relative ratios of the genes among
42 subjects. “*” behind the gene name indicated this gene was found significantly (p < 0.05) lower in HBC than in CT, and even lower in ALC than
in HBC samples. “Δ” indicated the gene was correlated significantly with Child-Pugh score. The number in front of the gene names indicated the
functional category which they belong to. 1. Amino acid biosynthesis and metabolism; 2. Carbohydrate metabolism; 3. Glycan biosynthesis and
metabolism; 4. Nucleotide metabolism; 5. Cofactor biosynthesis; 6. Lipid metabolism; 7. Isoprenoid biosynthesis.
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phosphate limitation (pstA, pstB, pstC and pstS), and
osmotic stress (proV).
(iii) Virulence. Functional genes associated with bacterial
virulence were found over-represented in ALC samples
compared to CT and HBC. The signal intensities of the
genes encoding the bacterial secretion system (type_-
Ш_secretion), catabolite activator protein (cap), iron-
regulated TonB-dependent receptor (iro), pilin protein
(pilin), and sortase family protein (srt), were significantly
(p < 0.001) higher in ALC than in HBC and CT.
(iv) Antibiotic resistance. Regarding antibiotic resistance,
5 genes were detected in significantly (p < 0.05) higher
abundance in ALC than other groups, including genes
for ABC_antibiotic_transporter, ß-lactamase_C,
MFS_antibiotic, SMR_antibiotics, and Tet genes.(v) Metal resistance. Functional genes associated with
metal resistance were found over-represented in ALC
samples compared to CT and HBC. The signal inten-
sities of the genes encoding arsenite oxidase (aoxB), ar-
senate reductase (ArsC), cadmium-translocating P-type
ATPase (CadA), copper-transporting P-type ATPase
(CopA), heavy metal efflux pump protein (czcA, czcD,
ZntA), RND efflux system outer membrane lipoprotein
(silC), tellurite resistence protein (TerC, TerD, TerZ),
were found singnificantly (p < 0.05) higher in ALC than
in HBC and CT.
Discussion
Although several studies have reported composition varia-
tions between cirrhotic patients and healthy controls, little
is known about bacterial gene content and their potential
Figure 5 Correlation between Child-Pugh score and the signal intensity of functional genes. Seven genes correlated negatively with the
severity of liver disease, as estimated by the Child-Pugh score, including genes for genes for carbohydrate metabolism (transaldolase) (Figure 5A),
glycan metabolism (phospho-N-acetylmuramoyl-pentapeptide transferase gene) (Figure 5B), amino acids synthesis (aspartate-ammonia ligase,
serine-tRNA ligase and glutamate decarboxylase A and B PLP-dependent gene) (Figure 5C, D, and E), and nucleotide metabolism (IMP dehydrogenase
gene and adenylosuccinate synthetase gene) (Figure 5F, G). The gene name is on the top of each figure, with the functional category name in
brackets. The Spearman Rank correlation (r) and probability (p) with Bonferroni correction was used to evaluate statistical importance.
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is a growing recognition of the need to study the func-
tional profile of fecal microbiota. Here we have presented
a functional gene array-based analysis of fecal microbiota
in patients with alcoholic cirrhosis and HBV-related
cirrhosis.
Different methods can be used to study complex micro-
bial populations. Recently, the development of the new-
generation sequencing technologies challenged the use of
DNA microarrays in microbial community studies. The
main limitation of microarrays is their inability to reveal
novel species in any samples, since the arrays can only
detect those sequences for which they contain probes.However, there are several main advantages of microarrays,
include (i) ability to profile one sample at a time, which is
useful in clinical studies and as a diagnostic tool; (ii) quanti-
tative nature of the acquired data allowing direct compari-
son between samples; (iii) quick sample preparation and
short processing and data acquisition time (only 24 hours
from sample to data using GeoChip); (iv) currently lower
costs compared with shotgun sequencing; and (v) resistance
to contaminants of host genome, which is useful for mu-
cosa samples containing a large percentage of host DNA
[19,20].
Although a few samples overlapped, there is a trend of
separation between cirrhosis subjects and controls.
Figure 6 Abundance distributions of the 92 functional genes in response to alcohol consumption. This is a heat map showing abundance
distributions of the 92 functional genes in response to cirrhosis. The column is the sample, with the sample name and cluster matrix on the top
of the figure. The row is the gene signal intensity, with the gene name on the right. The colour intensity indicates difference in signal intensities.
To show the distribution of the genes with lower abundance, the colored squares of each row were scaled to indicate the relative ratios of the
genes among 42 subjects. The number in front of the gene names indicated the functional category which they belong to. 1. Carbohydrate
metabolism; 2. Glycan biosynthesis and metabolism; 3. Energy process; 4. Antibiotic resistance; 5. Virulence; 6. Metal resistance; 7. Organic
remediation; 8. Stress response.
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were mostly related to nutrient metabolism (Figure 3).
Our results indicated that the metabolic potential of the
gut microbiota was significantly affected, analogous to a
previous study which reported a decrease in concentra-
tion of a large number of metabolites in patients with
cirrhosis based on metabolomic analysis of feces sam-
ples [21]. The exact reason for reduced gut microbial
metabolic potential in cirrhotic patients remains un-
clear. The fact of low protein diet in the majority of cir-
rhotic patients may play a role in it. Although not
recommended, patients with cirrhosis usually took low
protein diet to avoid hepatic encephalopathy [22]. The
effect of diet on gut microbiome has been verified in
several studies [23,24]. A controlled-feeding study of 10
subjects showed that microbiome composition changed
detectably within 24 hours of initiating a high fat/low
fiber or low fat/high fiber diet [25]. In the current study,
the microbiome of cirrhosis had a lower relative abun-
dance of genes associated with the biosynthesis and
metabolism of several amino acids, including leucine (2-
isopropylmalate synthase gene), serine (serine-tRNA lig-
ase gene and L-threonine aldolase gene), cysteine
(serine O-acetyltransferase gene and cysteine synthase
A gene), and valine (valine-pyruvate aminotransferase
gene) (Figure 3). Biosysthesis of amino acids are critical
for the growth of all microbes, but the amount and pro-
file of amino acids produced, and production of other
protein-containing metabolites have been reported to
vary depending on dietary composition in animal stud-
ies [26,27]. Malnutrition has increasingly been acknowl-
edged as an important prognostic factor, which can
influence the clinical outcome of cirrhotic patients [28].
Alcoholic beverages, which contribute little to the nutri-
tional requirements of the body, are usually associated
with food deficiency due to decreased appetite [29]. Al-
cohol ingestion has been shown to decrease vitamin B12
absorption in volunteers after several weeks of intake
[30]. In relation to this, our data revealed that cobalt
chelatase gene was significant underrepresented in cir-
rhosis groups, especially in alcoholic cirrhosis group.
Cobalt chelatase is an important pathway in vitamin B12
biosynthesis [31]. Together with diet alterations, re-
duced metabolic potential of gut microbiome might in-
crease the risk of malnutrition in cirrhosis.
Another class of functions changed in the cirrhosis
groups was bile salt metabolism. Bile acids, drugs and
toxins undergo extensive enterohepatic circulation, which
is also called gut-liver axis [32]. Bile acids play a major role
in several hepatic and intestinal diseases. Intestinal bac-
teria are known to participate in bile acid metabolism by
generating secondary bile acids (deconjugation, dehydrox-
ylation) [17]. The initial “gateway” reaction in the bacterial
metabolism of conjugated bile acids is mediated by bilesalt hydrolase [33]. In cirrhosis, decrease in intestinal
intraluminal concentrations of bile acids have been as-
cribed to decrease secretion and increased deconjugation
by enteric bacteria [2]. Nevertheless, our results demon-
strated the abundance of conjugated bile salt hydrolase
gene was significantly lower in cirrhosis than in controls.
In a recent metagenomic research of patients with HBV-
related cirrhosis using high-throughput sequencing, genes
annotated as bile salt hydrolases were also detected in
higher abundance in the normal microbiota than in the
cirrhotic microbiota [5]. In particular, cirrhotic patients
showed an altered fecal bile acid profile with a decreased
conversion of primary to secondary fecal bile acids [34]. It
is thus tempting to speculate that decrease synthesis of
bile acids in the liver contributes more importantly to de-
crease in intestinal intraluminal concentrations of bile
acids in cirrhosis.
Enzyme responsible for butyrate metabolism (butyrate
kinase gene) was found in less abundant in both cirrhosis
groups, especially in alcoholic cirrhosis group (Figure 4).
Our results are in agreement with the 16S rRNA based
analysis, which shows that many of the bacterial genera
significantly less abundant in cirrhotic patients are butyr-
ate producers and mucin degraders, such as Faecolibacter-
ium and Prevotella [35]. Butyrate is known as the
principal energy source for colonocytes and may fortify the
intestinal mucosal barrier by stimulating mucin synthesis
[36]. Recent endoscopic studies reveal mucosal alterations
in the gastrointestinal tract including inflammatory-like
changes and vascular lesions in cirrhosis [37]. Linking to-
gether these observations, a microbiota-dependent reduc-
tion of butyrate production may possibly contribute to the
nutritional status of epithelial cell in the intestine in cirrho-
sis, and potentially lead to mucosal changes, hypertensive
enteropathy and bacterial translocation indirectly.
The current results from the array analysis showed con-
siderable variations of the community functional structure
were observed in response to alcohol consumption. Higher
microbial richness and genetic diversity were observed in
ALC samples than in HBC or CT samples. The bacterial
genomes have been shown to be highly plastic and are fre-
quently reorganized through genetic rearrangements and
gene transfer, which can help them adapt to distinct eco-
logical conditions [38]. High level of heterogeneity and di-
versity among strains were observed under stressful
ecosystem such as high ethanol content, low pH and
temperature [39]. Alcohol ingested orally is transported to
the colon by blood circulation, and due to its high water
solubility, intracolonic ethanol levels are equal to those in
the blood [40]. In patients with cirrhosis, extrahepatic etha-
nol metabolism, via microbial oxidation in the colon, is
responsible for a large portion of ethanol metabolism [41].
It was recently shown that low concentrations of alcohol
can enhance microbial activity in the human body. For
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tion stimulated the expression of genes involved in stress
response, and biofilm formation [42]. Treatment of S. aur-
eus with alcohol resulted in increased transcription of the
biofilm-promoting genes icaA and icaD, as well as the
antibiotic resistance gene mmpL (multidrug efflux pump),
the efflux pump gene mepA, and the sensor histidine kin-
ase gene vraS [43]. In relation to this, functional genes re-
lated to stress response and antibiotic resistance were
significantly over-represented in our study.
Our results also revealed great metabolic potential in the
alcoholic cirrhosis group for xenobiotic degradation. Nu-
merous gut microbial genes are related to xenobiotic deg-
radation, including non-modified and halogenated aromatic
compounds [44]. More than 700 aromatic compounds have
been isolated and identified from various wines, which de-
rive from by-products of yeast fermentation and additives.
Phthalates are a group of industrial chemicals that have be-
come ubiquitous environmental contaminants because of
their widespread usage and high persistence in the environ-
ment [45]. Phthalates in alcoholic beverages might be from
two sources: the migration from packaging materials and
the use of diethyl phthalate as a denaturing agent for
alcohol [46]. The abundance of phtA genes, encoding
phthalate 4, 5-dioxygenase, was significantly higher in ALC
than in HBC or CT samples. Long-term alcohol consump-
tion could potentially lead to the enriched genes in
phthalates degradation. Moreover, our results revealed
metabolic potential in alcoholic cirrhosis group for benzo-
ate metabolism, such as bclA gene, nagG gene and 4HBH
gene (Figure 6). Benzoate could enter the tricarboxylicacid
cycle, and might constitute a potential energy source [47].
Aromatic compound degradation may allow for the utilisa-
tion of a wider array of substrates that may be used for en-
ergy harvesting in alcoholic cirrhosis.
In this study, we detected several genes which were
negatively correlated with Child-Pugh score (Figure 5).
Our results offer the possibility of using functional genesTable 1 Characteristics of study groups
Alcoholic cirrhosis
(n = 12)
Age 52.7 ± 13.0
Gerder (M/F) 9/3
BMI 20.3 ± 2.9
Alb 36.8 ± 6.3
INR 1.3 ± 0.2
TB 55.0 ± 33.9
Crea 70.0 ± 15.2
CP 7.7 ± 2.1
Note. 1. Age, BMI, CP, Alb, INR, TB, and Crea were expressed as mean ± SD. 2. Measu
Abbreviations: BMI body mass index, CP Child-Pugh score, TB total bilirubin, PT prot
serum creatine.as biomarkers to estimate the severity of liver cirrhosis.
Nevertheless, obtaining cultures of microbes is essential
for validating these hypotheses. Furthermore, since con-
siderable variations of the community functional structure
were observed in response to alcohol consumption, indi-
viduals with alcohol consumption with or without liver
disease should also be compared to validate such links in
future studies. In addition, DNA-based array analysis de-
tects only the functional potential of microbial communi-
ties, but not necessarily the actual functional activity. To
understand functional activities, RNA-based array analysis
is needed in future studies.
Conclusions
Functional gene array (GeoChip 4.0 + HuMiChip 1.0)
was utilized to study the gut microbiome in alcoholic
and HBV-related cirrhosis patients and controls in this
study. Our array data indicated that the functional
composition of fecal microbiomes was mostly influ-
enced by alcohol consumption, and secondly by cirrho-
sis. Alcohol consumption caused significant enrichment
of functional genes including xenobiotic metabolism
and virulence, while both cirrhosis groups were mark-
edly depleted in the functional genes involved in nutri-
ent processing, such as amino acid metabolism, lipid
metabolism and nucleotide metabolism. These results
have important implications for complications of cir-
rhosis (e.g., malnutrition and hypertensive enteropathy).
Therapeutic options aimed at adjusting the gut micro-
biome should be a potential treatment in cirrhosis.
Methods
Study population
A total of 42 individuals were recruited for this research,
including 3 groups: (1) 12 subjects with alcoholic cir-
rhosis (ALC); (2) 18 subjects with HBV-related cirrhosis
(HBC); (3) 12 subjects with normal liver function by
ultrasonographic examination and biochemical profilesHBV-related cirrhosis Healthy controls
(n = 18) (n = 12)
48.2 ± 11.5 45.3 ± 8.4
12/6 8/4
21.1 ± 2.3 20.6 ± 1.3
32.8 ± 5.1 48.1 ± 2.5
1.4 ± 0.4 1.1 ± 0.1
63.4 ± 56.4 16.7 ± 5.1
76.6 ± 16.6 67.1 ± 11.9
8.8 ± 2.0 None
re unit: Age (yr); BMI (kg/m2); TB (umol/L); PT (S); Alb (g/L); Crea (umol/L).
hrombin time, Alb, serum albumin, INR international normalized ratio, Crea,
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mass index, gender, and age.
Cirrhosis was diagnosed histologically in 17 out of 30
(57%) patients and on clinical and radiological grounds
in the remaining 13 (43%) patients for whom biopsy was
contraindicated by uncontrolled coagulapathy and/or
uncontrolled ascites. A diagnosis of alcoholic cirrhosis
was established if alcohol intake had been in excess of
80 g/day in men and 30 g/day in women for more than
5 years and if testing for viral, metabolic, and immune
etiologies was negative. The HBV-related cirrhotic pa-
tients and healthy controls had no history of alcohol
abuse. Subjects with HBV-related cirrhosis had HBV-
DNA detectable by PCR, and an absence of other (viral,
drug/toxin, autoimmune, or metabolic) causes of liver
disease. To avoid the influence of antibiotics or probio-
tics, exclusion criteria included a history of antibiotics/
probiotics (or prebiotics) treatment within the previous
8 weeks of sample collection. Clinical characteristics of
all groups are summarized in Table 1. Detailed charac-
teristics of patients (e.g., hepatic encephalopathy and as-
cites) are shown in Additional file 3: Table S3.
All subjects in this study provided their informed
consent in writing. The use of these subjects conformed
to the ethical guidelines of the 1975 Declaration of
Helsinki, and was approved by the First Affiliated Hospital
of Zhejiang University Institutional Review Broad.
Sampling and DNA extraction
All fecal samples were immediately frozen on collection
and stored at −70°C before analysis. Fecal DNA was ex-
tracted with the QIAamp DNA Stool Mini Kit (Qiagen,
Valencia, CA, USA) as described previously [4]. DNA
quality was assessed with a ND-1000 spectrophotometer
(Nanodrop Inc., Wilmington, DE, USA). DNA concen-
trations were quantified with Quant-It PicoGreen Kit
(Invitrogen Carlsbad, CA, USA) and 2 μg DNA was used
for functional gene array hybridization.
Array analysis
Details for labeling, hybridization, image processing and
data processing were described previously [48,49].
Probes that were detected in less than 10% of each
group were removed.
Statistical analysis
All hybridization data is available at the Institute for En-
vironmental Genomics, University of Oklahoma (http://
ieg.ou.edu/). Detrended correspondence analysis (DCA)
was performed by the vegan package in R 2.9.1 (R De-
velopment Core Team 2006). Correlation between vari-
ables was computed by Spearman Rank correlation. To
minimize false significant correlations, results were ad-
justed for multiple testing within each category usingthe Bonferroni correction. One way ANOVA with
Tukey’s test was used to evaluate the difference in func-
tional categories among the three groups. The one way
ANOVA and Spearman Rank correlation were con-
ducted in SPSS version 11.0 for Windows (SPSS Inc.,
Chicago, IL, USA).
Additional files
Additional file 1: Table S1. Summary of probe and covered coding
sequence information of GeoChip 4 based on gene categories.
Additional file 2: Table S2. Summary of probes and covered coding
sequence information of HuMiChip 1.0 based on gene categories.
Additional file 3: Table S3. Clinical Information Summary of Patients in
Study.
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